Dipyrazoles as central nervous system agents

Details for Australian Patent Application No. 2006227729 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors MacDonald, Douglas; Sher, Rosy; Kosley, Raymond W.

Agent Watermark

Pub. Number AU-B-2006227729

PCT Pub. Number WO2006/101903

Priority 60/662,195 16.03.05 US

Filing date 15 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 13 October 2011

International Classifications

C07D 231/22 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 231/26 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/101903 Priority application(s): WO2006/101903

13 October 2011 Application Accepted

  Published as AU-B-2006227729

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006227730-A management console providing an interface for featured sets of digital automation systems

2006227724-Systems, kits and methods for treatment of the spinal column using elongate support members